When Kylie Jenner famously admitted that her signature pout was the result of lip fillers, there was a significant increase in interest and uptake of the cosmetic procedure. That’s the power of social media.
Could Two Targeted Therapies Be Better Than One in Lupus?
In a somewhat daring phase II study, the Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) was effective for reducing disease activity in systemic lupus erythematosus (SLE),
June 27, 2024